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Background: The increased incidence of impaired glucose tolerance (IGT), are serious public health issues, and
several studies link sleeping disorders with increased risk of developing type 2 diabetes, impaired glucose tolerance
and insulin resistance (IR). This study explore how self-reported lack of sleep and low vitality, are associated with IGT
in a representative Swedish population.
Methods: A cross-sectional survey conducted in two municipalities in South-western Sweden. Participants aged
30–75 were randomly selected from the population in strata by sex and age. Altogether, 2,816 participants were
surveyed with a participation rates at 76%. Participants with normal glucose tolerance (n=2,314), and those with IGT
(n=213) were retained for analyses. The participants answered a questionnaire before the oral glucose tolerance test
(OGTT). Associations for questions concerning sleeping disorders, vitality and IGT were analysed using logistic
regression and were expressed as odds ratios (OR) with 95% CI.
Results: In men a statistically significant age-adjusted association was found between self-reported lack of sleep
and IGT: OR 2.4 (95% CI: 1.1-5.4). It did not weaken after further adjustment for body mass index (BMI), smoking,
education, and leisure time physical activity 2.3 (1.0-5.5, p=0.044). No such associations were found in females.
Corresponding age-adjusted associations between low vitality and IGT in both men 2.8 (1.3-5.8), and women 2.0
(1.2-3.4) were successively lost with increasing adjustment.
Conclusions: Insufficient sleep seems independently associated with IGT in men, while low vitality was not
independently associated with IGT neither in men nor women, when multiple confounders are considered. IGT
should be considered in patients presenting these symptoms, and underlying mechanisms further explored.
Keywords: Impaired glucose tolerance, Fatigue, Sleeping disorders, Health conversation, Primary health careBackground
The increased incidence of impaired glucose metabolism
(IGM) [1,2] and its association with vascular complica-
tions [3] are serious public health issues. Usually, type 2
diabetes is preceded by a period of hyperinsulinemia as
a consequence of insulin resistance (IR), impaired glu-
cose tolerance (IGT) and/or impaired fasting glucose
(IFG) [4]. Individuals with IFG have predominantly an
increased hepatic insulin resistance and differ from those* Correspondence: ulf.lindblad@allmed.gu.se
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distribution, and reproduction in any mediumwith IGT who primarily have insulin resistance in skel-
etal muscle [5]. Estimates predict that 60% of people
who develop diabetes have IGT or IFG about 5 years
earlier [6]. Sleeping disorders have adverse consequences
on multiple systems [7] and several studies link sleeping
disorders with IGM and increased risk of developing
type 2 diabetes, IGT and IR [8-10]. The causal effects of
sleep disorders and the underlying path physiological
mechanisms involved have not been fully elucidated [11]
and the association between diabetes, obesity and sleep
disorders may be described as a vicious circle [12].
Though several behavioral factors may influence these
mechanisms, low physical activity and obesity are thetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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IGM, sleep function and experienced well-being.
However, the question remains if the experience of
not getting enough sleep to feel thoroughly rested is
causally related to the underlying pathophysiological
mechanisms in the development of IGT. The feeling of
not being fully rested may also be connected to the feel-
ing of low vitality, and fatigue may be one way to ex-
press this [13]. Interestingly, we have previously found
that people with IGT similarly describe fatigue as ab-
normal day time sleepiness that increases the need for
rest and a feeling of not being as strong as before [13].
An International Diabetes Federation expert committee
also recommends professionals consider that patients
with IGM may also suffer from sleeping disorders, low
vitality and fatigue, and vice versa [14]. Considering that
both the American Diabetes Prevention Program [15],
and the Finnish Diabetes Prevention Study on IGT [16],
using diet and physical activity showed dramatic effects
in the prevention of overt diabetes, while similar evi-
dence are lacking for IFG, the focus for preventive strat-
egies is on IGT.
Our aim was accordingly to further characterise sub-
jects with early disturbances in the glucose metabolism
being at risk for development of type 2 diabetes. To
avoid bias due to secondary effects we identified individ-
uals not yet aware of their condition to explore the asso-
ciation of self-reported lack of sleep and low vitality in
relation to IGT in a representative Swedish population.Figure 1 Flowchart of the Skaraborg Project 2002–2005. The total num
participants had incomplete OGTT, and of those with NGT or IGT 19 partici
did not respond to the question on vitality. The current study populations
(vitality), respectively.Methods
Study population
The present study is a cross-sectional survey carried out
in 2002–2005 in two municipalities in South-western
Sweden. Skaraborg County is located in the southwest of
Sweden and in the year 2000 had approximately 270,000
inhabitants. The vast majority have lived in Sweden for
generations and only a few per cent are immigrants from
countries outside Scandinavia. Within the Skaraborg
Project a survey was conducted in 2002–2005 in the
municipalities of Vara and Skövde, as previously de-
scribed in detail (n=2816, with a participation rate of
76%) [17]. The participants aged 30–75 were randomly
selected from the population in strata by sex and age.
Selected participants were invited by mail to participate
in a health survey with two visits. The further selection
of the current study population of participants with nor-
mal glucose tolerance (NGT) or IGT is shown in Figure 1
(n=2,314, and n=213, respectively). Two subjects had in-
complete OGTT, 19 participants did not answer the
question on sleep, and 50 subjects did not respond to
the question on vitality. The current study populations
thus included 2508 participants (lack of sleep) and 2477
(vitality), respectively (Figure 1).
Study procedures
On the first study visit, specially educated laboratory as-
sistants obtained blood samples in the morning after an
overnight fast (10 h). Plasma glucose was analysed at theber of participants 2,816, and the participation rate was 76%. Two
pants did not answer the question on lack of sleep, and 50 subjects
thus included 2508 participants (lack of sleep) and 2477
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During the OGTT, the participants were asked to answer
a questionnaire covering information about medical
history, current medications, socio-economic factors,
smoking habits, leisure time physical activity (LTPA),
self-rated health and sleeping disorders. The question re-
garding sleeping disorders used for this paper was: Do
you think that you get enough sleep to feel thoroughly
rested? The participants chose one of three alternative
answers: 1. Yes, usually. 2. Yes, but not often enough. 3.
No, never or almost never. The question regarding
symptoms of vitality was: Have you during the last four
weeks felt full of vitality? The six reply alternatives were:
1. Yes, all of the time 2. Yes, most of the time. 3. Yes, a
lot of the time. 4. Some of the time. 5. No, almost never.
6. No, not at all. The question was categorized, all/most
of the time, a lot of/some of the time and almost never/
not at all, in 3 categories. The question regarding LTPA
had four answer alternatives and low physical activity
levels 1 and 2, while levels 3–4 were considered physic-
ally active [17]. Information on alcohol consumption
was collected by a validated questionnaire measuring the
total intake of alcohol by beer, wine, and spirits over a
30-days period [18]. A standard resting blood pressure
and the anthropometric measures were measured on a
second visit two weeks later by two specially trained
nurses. Current smoking was defined as daily smoking
(yes/no). Concentrations of serum cholesterol were de-
termined using standard procedures. All participants
were tested for fasting plasma glucose (FPG), and an
OGTT was performed in all patients without a known
diagnosis of diabetes. Diagnoses of IFG, IGT and dia-
betes were determined according to recommendations
by WHO [19].Statistical analyses
Characteristics of participants with IGT were presented
using participants with normal glucose metabolism as a
reference, using SPSS Base System 19.0 for Windows for
data analyses. Continuous variables were presented as
age-adjusted means with SD (standard deviation). Differ-
ences in means between groups were analysed by GLM
(Generalized linear model) and associations between cat-
egories were analysed using logistic regression and
expressed as odds ratios (OR) with 95% CI. All compari-
sons between groups were adjusted for differences in age
and other covariates were included when indicated. All
tests were 2-sided and statistical significance was as-
sumed at p <0.05.Ethical approval
The study was approved by the Regional ethical review
board, Gothenburg University, Sweden (2001-10-15,Dnr. Ö 199–01) and written consent was obtained from
each participant.
Results
IGT was diagnosed in 213 participants: 86 men and 127
women (Figure 1). Table 1 shows that both men and
women with IGT were older than men and women with
NGT (Table 1), and they both also had a more athero-
genic risk factor profile than participants with NGT.
Low level of physical activity, a low level of education,
and a diagnosis of hypertension were also more common
in both men and women with IGT.
The associations between self-reported lack of sleep
and IGT in men and women are shown in Table 2. The
OR for IGT in men with a lack of sleep was 2.5 (1.1-5.9),
when adjusted for age, BMI, smoking, low level of edu-
cation, low physical activity and alcohol consumption.
No corresponding association was seen in women.
Table 3 shows that when low and severely impaired vi-
tality were compared to normal, significant age-adjusted
associations were found between the lowest level of vi-
tality and IGT in both men 2.8 (1.3-5.8), and women 2.0
(1.2-3.4). This association remained in men when further
adjusting for BMI, smoking, or level of education but
was lost when level of LTPA was entered into the model.
In women, the corresponding association remained sig-
nificant, but was just lost when also alcohol consump-
tion was entered to the model.
We found no associations between lack of sleep and
low vitality with IFG (Tables 2 and 3).
Discussion
We found a significant association between self-reported
lack of sleep and IGT in men that remained after adjust-
ment for potential confounders such as obesity and
health behaviours. No such association was found in
women. Furthermore, a significant association was found
between low vitality and IGT in both men and women.
While the association was more robust in women, it was
lost in men when other patient-related factors were con-
sidered. The study also confirmed that both men and
women with IGT have a more serious cardiovascular
disease risk factor profile than participants with NGT. A
worse risk factor profile was also revealed in both men
and women with IFG as compared to NGT, however, we
found no associations with lack of sleep or low vitality.
In support of our findings, the Quebec Family Study
[20] found that both short and long total sleeping time
predicted type 2 diabetes/IGT in adult men and women.
Clinical effects of sleep deprivation are associated with
common symptoms such as sleepiness, increased fatigue,
and low motivation [21], a finding that is in agreement
with the results of this study. Furthermore, voluntary
sleep reduction is increasingly becoming a way of life –
Table 1 Characteristics of 1.400 men and 1.416 women with normal glucose tolerance (NGT), impaired fasting glucose
(IFG) and impaired glucose tolerance (IGT) in the Vara-Skövde cohort 2002-2005
NGT IFG IGT
(n=1130) (n=94) (n=86)
Characteristics Mean (SD) Mean (SD) p Mean (SD) p
Men
Age (years) 45.9 (10.7) 53.4 (11.6) <0.001 56.0 (12.3) <0.001
SBP (mm Hg) 122 (14.3) 129 (17.2) 0.093 133 (19.4) 0.001
DBP (mm Hg) 71 (9.7) 74 (10.3) 0.157 76 (11.6) 0.021
S-Cholesterol 5.4 (1.0) 5.2 (1.0) 0.009 5.6 (1.1) 0.559
S-triglycerides 1.4 (0.8) 1.6 (0.9) 0.003 2.0 (1.6) <0.001
S-HDL Cholesterol 1.22 (0.28) 1.14 (0.35) 0.006 1.1 (0.3) 0.004
Body mass index (kg m-2) 26.5 (3.3) 28.1 (3.9) <0.001 28.3 (4.1) <0.001
Waist hip ratio (m m-1) 0.93 (0.1) 0.96 (0.1) <0.001 0.98 (0.1) <0.001
Waist (cm) 94 (9.2) 99 (10.3) <0.001 100 (11.1) <0.001
NGT IFG IGT
(n=1130) (n=94) (n=86)
Characteristics n (%) n (%) p n (%) p
Men
Lack of sleep 418 (37) 27 (29) 0.775 33 (39) 0.025
Low vitality 457 (41) 38 (40) 0.903 41 (50) 0.056
Daily smoking 168 (15) 18 (19) 0.279 11 (13) 0.638
Low physical activity 635 (58) 60 (65) 0.303 62 (77) 0.002
Hypertension 111 (9) 24 (26) 0.063 29 (34) 0.005
Living alone 222 (20) 16 (17) 0.801 30 (35) <0.001
Low level of education 307 (28) 40 (44) 0.570 39 (49) 0.963
NGT IFG IGT
(n=1184) (n=35) (n=127)
Characteristics Mean (SD) Mean (SD) p Mean (SD) p
Women
Age (years) 46.2 (10.9) 56.3 (11.1) <0.001 53.7 (12.8) <0.001
SBP (mm Hg) 117 (1.0) 131 (17.7) 0.022 133 (22.6) <0.001
DBP (mm Hg) 68 (9.7) 72 (10.1) 0.435 74 (10.9) <0.001
S-Cholesterol 5.1 (1.1) 5.9 (1.0) 0.066 5.5 (0.9) 0.800
S-triglycerides 1.1 (0.54) 1.7 (0.7) <0.001 1.5 (0.7) <0.001
S-HDL Cholesterol 1.4 (0.33) 1.3 (0.36) 0.001 1.3 (0.4) <0.001
Body mass index (kg m-2) 26.1 (4.8) 30.1 (6.3) <0.001 29.6 (6.2) <0.001
Waist hip ratio (m m-1) 0.82 (0.1) 0.87 (0.1) 0.001 0.86 (0.1) <0.001
Waist (cm) 84 (12.5) 94 (14.4) <0.001 92 (14.5) <0.001
NGT IFG IGT
(n=1184) (n=35) (n=127)
Characteristics n (%) n (%) p n (%) p
Women
Lack of sleep 466 (40) 16 (47) 0.195 52 (41) 0.413
Low vitality 698 (52) 21 (60) 0.301 74 (61) 0.048
Daily smoking 246 (21) 9 (26) 0.272 23 (18) 0.706
Low physical activity 791 (69) 26 (79) 0.336 107 (86) <0.001
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Table 1 Characteristics of 1.400 men and 1.416 women with normal glucose tolerance (NGT), impaired fasting glucose
(IFG) and impaired glucose tolerance (IGT) in the Vara-Skövde cohort 2002-2005 (Continued)
Hypertension 111 (10) 7 (20) 0.872 46 (36) <0.001
Living alone 225 (19) 6 (17) 0.381 26 (21) 0.679
Low level of education 236 (20) 18 (512) 0.228 44 (36) 0.759
NGT normal glucose tolerance, IFG impaired fasting glucose, IGT impaired glucose tolerance. SBP systolic blood pressure, DBP diastolic blood pressure.
Data are means and (SD), or numbers and proportions (%). IFG and IGT were compared to NGT using general linear models for continues variables, and logistic
regression for categorical variables and adjusting for differences in age.
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studies show that nearly 30% of the middle-aged popu-
lation reported sleeping less than 6.5 h per night [23].
As a consequence, reports of day-time sleepiness have
become more frequent during recent years [24]. The
cause of sleep-loss is multi factorial, although obesity is
considered an important risk factor for obstructive
sleep apnea (OSA) [25]. Accordingly, in the FIN-D2D
survey [26], middle-aged men with sleep-disordered-
breathing (SDB) had an increased incidence of type 2
diabetes and abnormal glucose tolerance. However, no
corresponding association has been found in women in
either the FIN-D2D survey [26] or the study of women
in Gothenburg [27].
The significant association found between level of vi-
tality and IGT was robust in women, but was diluted
and lost in men when successively accounting for otherTable 2 Association between lack of sleep and impaired gluco
using normal glucose tolerance as reference
None Intermediate Severe
OR OR 95% CI OR 95% CI
Men
Lack of sleep and the association with IGT
Adjusted for age
1 1.6 (0.9-2.7) 2.4 (1.1-5.4)
Adjusted for age, BMI
1 1.5 (0.9-2.6) 2.3 (1.0-5.2)
Adjusted for age, BMI, smoking
1 1.5 (0.9-2.6) 2.4 (1.1-5.3)
Adjusted for age, BMI, smoking, level of education
1 1.4 (0.8-2.5) 2.6 (1.2-5.9)
Adjusted for age, BMI, smoking, level of education, level of physical activity
1 1.3 (0.7-2.3) 2.3 (1.0-5.5)*
Adjusted for age, BMI, smoking, level of education, level of physical activity, alco
1 1.3 (0.7-2.3) 2.5 (1.1-5.9)
Lack of sleep and the association with IFG
Adjusted for age
1 1.0 (0.6-1.7) 0.7 (0.2-1.9)
IFG impaired fasting glucose, IGT impaired glucose tolerance, BMI body mass index.
Associations were estimated using logistic regression and were expressed by OR an
*p=0.044.patient-related factors. As fatigue is one of the more
common presenting symptoms of type 2 diabetes, this is
interesting. Physical activity came out as an explanatory
factor in men, but an interaction should be expected in
both genders by virtue of its strong association with in-
sulin resistance and consequently the development of
both IGT and type 2 diabetes [28]. Since physical activity
is known to improve mood, and a good mood most
likely increase the motivation for physical activity it may
thus also be associated with the vitality factor [29].
As shown in a prospective study, psychological distress
such as fatigue, anxiety and insomnia increases the risk
for prediabetes and type 2 diabetes in Swedish middle-
aged men [30]. There is a common belief that day-time
sleepiness is normal or related to poor life style or lazi-
ness, especially if it interferes with daily functions
[28]. However, OSA often characterized by daytimese tolerance and impaired fasting glucose, respectively,
None Intermediate Severe
OR OR 95% CI OR 95% CI
Women
1 1.2 (0.8-1.8) 1.1 (0.5-2.2)
1 1.1 (0.7-1.7) 1.0 (0.5-2.1)
1 1.1 (0.7-1.6) 1.0 (0.5-2.1)
1 1.1 (0.7-1.7) 1.1 (0.5-2.2)
1 1.1 (0.7-1.7) 1.0 (0.5-2.2)
hol consumption
1 1.1 (0.7-1.7) 1.1 (0.5-2.1)
1 1.5 (0.7-3.2) 1.9 (0.6-5.9)
d 95% confidence intervals.
Table 3 Association between low vitality and impaired glucose tolerance and impaired fasting glucose, respectively,
using normal glucose tolerance as reference
None Intermediate Severe None Intermediate Severe
OR OR 95% CI OR 95% CI OR OR 95% CI OR 95% CI
Men Women
Low vitality and the association with IGT
Adjusted for age
1 1.4 (0.8-2.2) 2.8 (1.3-5.8) 1 1.3 (0.9-2.0) 2.0 (1.2-3.4)
Adjusted for age, BMI
1 1.4 (0.8-2.3) 2.7 (1.3-5.7) 1 1.3 (0.8-1.9) 1.7 (1.0-3.0)
Adjusted for age, BMI, smoking
1 1.4 (0.8-2.3) 2.8 (1.3-5.8) 1 1.3 (0.8-2.0) 1.8 (1.0-3.1)
Adjusted for age, BMI, smoking, level of education
1 1.3 (0.8-2.3) 2.2 (1.0-5.0) 1 1.4 (0.9-2.1) 1.9 (1.1-3.3)
Adjusted for age, BMI, smoking, level of education, level of physical activity
1 1.1 (0.6-1.9) 2.0 (0.9-4.4) 1 1.3 (0.8-2.0) 1.8 (1.0-3.2)*
Adjusted for age, BMI, smoking, level of education, level of physical activity, alcohol consumption
1 1.1 (0.6-2.0) 2.0 (0.9-4.6) 1 1.3 (0.8-2.1) 1.7 (0.9-3.0)
Low vitality and the association with IFG
Adjusted for age
1 1.0 (0.7-1.7) 1.0 (0.4-2.3) 1 1.2 (0.5-2.5) 2.3 (0.9-5.8)
IGT impaired glucose tolerance, IFG impaired fasting glucose, BMI body mass index.
Associations were estimated using logistic regression and were expressed by OR and 95% confidence intervals.
*p=0.048.
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cluding age and obesity, but the direction of causality
may go both ways [28]. Consequently, OSA should also
be considered when these symptoms are investigated.
The underlying mechanism also involving genetics, for
example a mutation in the melatonin receptor 1B,
should also be considered [31].
Our study question on sleep function did not account
for sleep duration or possible SDB. However, the differ-
ence between men and women in the association be-
tween lack of sleep and IGT is consistent with the
findings in the FIN-D2D study [26], and might thus be
explained by the fact that men are more exposed to
OSA, or more susceptible to the effects of OSA. Never-
theless, our findings were not diluted when BMI was ad-
justed for. Unfortunately, we did not measure breathing
pattern during sleep directly or by questionnaire. In a
previous Swedish study, men were also more susceptible
to psychological distress in the association with predia-
betes than women [30]. We found no corresponding pat-
tern in the association with low vitality. This may
probably be explained by low vitality being derived from
other mechanisms than psychological distress.
Strengths and limitations of the study
This study is based on a large, random population
sample with a high participation rate, making theresults generalizable to this and other similar popula-
tions. A further strength of this study is the enrolment
of both men and women over a wide age-band where
strategies of diabetes prevention are important. The
prevalence of IGT was also congruent with other stud-
ies from Sweden [30].
An OGTT was performed in each participant without
a known diagnosis of diabetes. According to recommen-
dations from WHO, an OGTT should be performed to
diagnose IGT as it is characterized by postprandial
hyperglycemia and separate from IFG that is character-
ized by fasting hyperglycemia. This procedure to identify
IGT is supported by experiences from other population
studies [32]. The questionnaires were completed before
the information of the results of the OGTT was avail-
able, and therefore none of the participants were aware
of their potential diagnosis of IGT when answering the
questionnaire. In this study we used self-reported infor-
mation on physical activity on physical activity in leisure
time, (LTPA). However, this question has shown good
validity when recently compared to objectively measured
total physical activity during 24 hour [33]. Limitations of
the study comes from it’s cross-sectional design, making
it impossible to decide on causality in associations.
Information on sleep function and vitality was self-
reported and not based on direct measurements; how-
ever, these questions have been used and validated in
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sleep was explored in the Minimal Insomnia Symptom
Scale (MISS) [34], and our question on vitality was in-
cluded in a validation of the SF-36 questionnaire [35]. The
question on self-experienced lack of sleep in this study is a
general perception on the sleep quality covering both sleep
duration and sleep quality as compared to instruments that
evaluate more specific domains of sleep quality like the
Pittsburg Slep Quality Index [36]. It still correlates well
with other characteristics of sleep function [34]. Finally, the
protocol did not comprise any measurements on OSA and
HbA1c was not measured in the complete sample, and
thus these important factors could not be accounted for.
Conclusions
There is a link between self-reported lack of sleep, low
vitality and IGT. Short sleep duration is a risk factor for
developing type 2 diabetes [37] and voluntary sleep re-
striction may contribute to the global epidemic burden
of type 2 diabetes [10]. More research is needed to de-
termine how quality of sleep and low vitality interact in
persons who are susceptible to developing IGT, thus fa-
cilitating improved strategies for prevention.
For health professionals, this study emphasizes the im-
portance of paying attention to patients’ symptoms of
sleep deficiency and low vitality. Patients with lack of
sleep and low vitality should be considered for evalu-
ation of a possible IGT in line with the IDF expert com-
mittee [14]. In particular, male patients with insufficient
sleep and related symptoms such as low vitality should
be tested generously for possible impaired glucose me-
tabolism, using OGTT more frequently. This is corres-
pondingly true for women expressing low vitality. Our
findings are in accordance with the current strategy of
opportunistic screening and primary care is the legitim-
ate setting for primary prevention of type 2 diabetes. Lis-
tening to the patients’ symptoms may be one way of
helping to identify persons at risk in order to prevent
the development of type 2 diabetes.
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